ADVERTISEMENT

AC Health starts building P2-B cancer care center

Published Jul 22, 2021 03:20 pm

AC Health, the healthcare arm of Ayala Corporation, has broken ground for the start of the construction of its P2-billion Healthway Cancer Care Center, the Philippines’ first dedicated specialty cancer hospital.

AC Health officially breaks ground for the construction of the Philippines’ first dedicated cancer specialty hospital on July 22. In the photo (L-R) are Chairman of Zodiac Medical Advisory, Dr. Gary Lorenzo, President and CEO of Zodiac Health Ventures, Inc. Nona Ong, FTI Vice President, JB Trinidad, Taguig City Mayor, Hon. Lino Cayetano, President and CEO of AC Health, Paolo Borromeo, DOH Secretary Francisco Duque and Ayala Corporation President and CEO, Fernando Zobel de Ayala.

In a statement, Ayala said that, amid its efforts to boost the private sector’s pandemic response, AC Health continues to work towards its goal of providing quality healthcare for all.

With cancer being the second leading cause of death in the Philippines, the 100-bed Healthway Cancer Care Center is Ayala Group’s response to the Cancer Control Act (RA 11215), which gives the private sector the green light to create cancer specialty hospitals and clinics.

In 2020 alone, over 150,000 cancer cases were recorded in the country. In the same year, 90,000 Filipinos succumbed to the dreaded disease.

Once completed in July 2023, Healthway Cancer Care Center will be the first comprehensive, dedicated cancer hospital in the country, offering a complete range of cancer services from screening, diagnosis, treatment to post-cancer care.

AC Health has partnered with Varian-CTSI, which provides clinical services and solutions to over 100 hospitals, clinics, and physician groups worldwide, in ensuring delivery of affordable yet high standards of cancer care in the country.

“Cancer is a critical public health problem with an enormous impact on patients, the families, and the healthcare system at large,” said AC Health Chairman Fernando Zobel de Ayala.

He noted that, “There is an urgent need to develop sustainable solutions. We need to increase awareness of the disease through patient education, improve the timeliness of diagnosis through rigorous screening programs, and minimize out-of-pocket cancer expenses through affordable cancer care.”

With the addition of Healthway Cancer Care Center, AC Health expands its healthcare portfolio alongside Healthway Clinics, Qualimed Hospitals, Generika Drugstores, IE Medica and MedEthix, and the HealthNow mobile app.

Meanwhile, during the groundbreaking ceremony, Ayala Corporation, together with AC Health, turned over 1,000 doses of flu vaccine to Taguig City.

The flu vaccine will serve to protect Taguig’s constituents against the infectious disease and its possible complications as the country focuses on beating COVID-19.

“With the donation of the flu vaccines through the #BrigadangAyala, we are optimistic that we will be able to lessen the burden of influenza, amidst the COVID-19 pandemic. We target to administer these vaccines for our priority beneficiaries namely, the Philippine National Police, Traffic Management Office, Barangay Health Workers, Bureau of Fire Protection and other frontliners,” said Taguig Mayor Lino Cayetano.

“The Ayala Group is delighted to support the City of Taguig in its efforts to protect the health of its constituents,” added AC Health President & CEO Paolo Borromeo.

Aside from the donation of flu vaccines, AC Health has worked closely with the City of Taguig to augment their COVID-19 vaccination efforts for their constituents across the A1-A5 priority groups.

At the onset of the pandemic, AC Health has been leading the Ayala Group’s COVID-19 response initiatives. It has worked closely with the DOH, IATF, and local governments to implement protocols across the group and spearhead key milestones, from setting up mega-isolation facilities and testing labs to securing vaccines for employees and other stakeholders.

As of July 13, 2021, AC Health has already administered more than 193,000 doses of COVID-19 vaccines to priority groups across LGUs, the Ayala Group, and partner companies.

ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ articles_filter_1564_widget.title }}

.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });

Sign up by email to receive news.